Interactions of Alzheimer amyloid-β peptides with glycosaminoglycans: Effects on fibril nucleation and growth

European Journal of Biochemistry

Volumn 266, Issue 3, 1999, Pages 1101-1110

  McLaurin, JoAnne ^a,b   Franklin, Trudy ^a   Zhang, Xiaoqiong ^a   Deng, Jianping ^a   Fraser, Paul E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

A peptides; Alzheimer's disease; Amyloid; Fibrillogenesis; Glycosaminoglycans

Indexed keywords

AMYLOID BETA PROTEIN; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; KERATAN SULFATE; PHOSPHATE; PROTEOGLYCAN; TRIFLUOROETHANOL;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CIRCULAR DICHROISM; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN INTERACTION; SENILE PLAQUE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CIRCULAR DICHROISM; GLYCOSAMINOGLYCANS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 0033572813     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00957.x     Document Type: Article

References (55)

1. 1. Sipe, J. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947-975.
2. 2. Fraser, P.E., Nguyen, J.T., Chin, D.T. & Kirschner, D.A. (1992) Effects of sulfate ions on Alzheimer ß β/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
3. 3. Gupta-Bansal, R., Fredcrickson, R.C.A. & Brunden, K.R. (1995) Proteoglycan-mediated inhibition of A β proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 270, 18666-18671.
4. 4. Shaffer, L.M., Dority, M.D., Gupta-Bansal, R., Frederickson, R.C.A., Younkin, S.G. & Brunden, K.R. (1995) Amyloid β protein (A β) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
5. 5. Castillo, G.M., Ngo, C., Cummings, J., Wight, T.N. & Snow, A.D. (1997) Perlecan binds to the β-amyloid proteins (A β) of Alzheimer's disease, accelerates A β fibril formation, and maintains A β fibril stability. J. Neurochem. 69, 2452-2465.
6. 6. Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, MB. & Blake, C.C.F. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729-793.
7. 7. Snow, A.D. & Kisilevsky, R. (1985) Temporal relationship between glyeosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study. Lab. Invest. L53, 37-44.
8. 8. Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J. & Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
9. 9. Snow, A.D., Nochlin, D., Sekiguchi, R. & Carlson, S.S. (1996) Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Exp. Neurol. 138, 305-317.
10. 10. Snow, A.D., Mar, H., Nochlin, D., Kresse, H. & Wight, T.N. (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytohem. 40, 105-113.
11. 11. Dewitt, D.A., Silver, J., Canning, D.R. & Perry, G. (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121, 149-152.
12. 12. Perry, G., Siedlak, S.L., Richey, P., Kawai, M., Cras, P., Kalana, R.N., Galloway, P.G., Scardin, J.M., Cordell, B., Greenberg, B.D., Ledbetter, S.R. & Gambetti, P. (1991) Neurophil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J. Neurosci. 11, 3679-3683.
13. 13. Su, J.H., Cummings, B.J. & Cotman, W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801-813.
14. 14. Goedert, M., Jakes, R., Spillantini, M.G., Hasegawa, M., Smith, M.J. & Crowther, R.A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
15. 15. Buée, L., Ding, W., Delacourte, A. & Fillit, H. (1993) Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 601, 154-163.
16. 16. Buée, L., Ding, W., Anderson, J.P., Narindrasorasak, S., Kisilevsky, R., Boyle, N.J., Robakis, N.K., Delacourte, A., Greenberg, B. & Fillit, H.M. (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 627, 199-204.
17. 17. Snow, A.D., Kinsella, M.G., Parks, E., Sekiguchi, R.T., Miller, J.D., Kimata, K. & Wight, T.N. (1995) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the β-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320, 84-95.
18. 18. Brunden, K.R., Richter-Cook, N.J., Chaturvedi, N. & Fredrickson, R.C.A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.
19. 19. Gupta-Bansal, R. & Brunden, K.R. (1998) Congo red inhibits proteoglycan and serum amyloid P binding to amyloid β fibrils. J. Neurochem. 70, 292-298.
20. 20. Jao, S., Ma, K., Talafous, J., Orlando, R. & Zagorski, M.G. (1997) Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid: Int. J. Exp. Clin. Invest. 4, 240-252.
21. 21. Huang, T.H.J., Fraser, P.E. & Chakrabartty, A. (1997) Fibrillogenesis of Alzheimer Aß peptides studied by fluorescence energy transfer. J. Mol. Biol. 269, 214-224.
22. 22. McLaurin, J., Franklin, T., Chakrabartty, A. & Fraser, P.E. (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloidβ fibril growth and arrest. J. Mol. Biol. 278, 183-194.
23. 23. Kirschner, D.A., Abraham, C. & Selkoe, D.J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc. Natl Acad. Sci. USA 83, 503-507.
24. 24. Halverson, K., Fraser, P.E., Kirschner, D.A. & Lansbury, P.T. (1990) Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry 29, 2639-2644.
25. 25. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149-163.
26. 26. Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A. & Teplow, D.B. (1996) On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA 93, 1125-1129.
27. 27. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I. & Schenk, D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
28. 28. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. & Cole, G. (1996) Memory deficits, A β elevation and amyloid plaques in transgenic mice. Science 274, 99-102.
29. 29. Barrow, C.J. & Zagorski, M.G. (1991) Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182.
30. 30. Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C., Beyreuther, K., Frank, R.W. & Rosch, P. (1995) Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233, 293-298.
31. 31. Terzi, E., Holzemann, G. & Seelig, J. (1995) Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642.
32. 32. McLaurin, J. & Chakrabartty, A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides; implications for neurotoxicity. J. Biol. Chem. 271, 26482-26489.
33. 33. Fraser, P.E., Nguyen, J.T., McLachlan, D.R., Abraham, C.R. & Kirschner, D.A. (1993) α l-antichymotrypsin binding to Alzheimer A β peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 61, 298-305.
34. 34. Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T. & Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol 145, 1030-1034.
35. 35. Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H. & Lansbury, P.T. Jr (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 763-767.
36. 36. Eriksson, S., Janciauskiene, S. & Lannfelt, L. (1995) α 1-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc. Natl Acad. Sci. USA 92, 2313-2317.
37. 37. McLaurin, J., Franklin, T., Fraser, P.E. & Chakrabartty, A. (1997) Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides. J. Biol. Chem. 273, 4506-4515.
38. 38. Webster, S. & Rogers, J. (1996) Relative efficacies of amyloid β peptide (A β) binding proteins in A β aggregation. J. Neurosci. Res. 46, 58-66.
39. 39. Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
40. 40. Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, CM., Radford, S.E., Blake, C.C.F. & Pepys, M.B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-793.
41. 41. Jarrett, J.T., Berger, E.P. & Lansbury, P.T. (1993) Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Biochemistry 32, 4693-4697.
42. 42. Jarrett, J.T. & Lansbury, P.T. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Cell 73, 1055-1058.
43. 43. Cai, X.-D., Golde, T.E. & Younkin, G.S. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
44. 44. Citron, M., Vigo-Pelfrey, C., Teplow, D.B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. & Selkoe, D. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA 91, 11993-11997.
45. 45. Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L. Jr, Eckman, C., Golde, T.E. & Younkin, S.G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (beta APP717) mutants. Science 264, 1336-1340.
46. 46. Stritmater, W.J. & Roses, A.D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 4725-4727.
47. 47. Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R.A., Greenberg, B. & Kisilevsky, R. (1991) High affinity interactions between the Alzheimer's β-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883.
48. 48. Small, D.H., Nurcombe, V., Reed, G., Clarris, H., Moir, R., Beyreuther, K. & Masters, C.L. (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 12, 4143-1150.
49. 49. Arrasate, M., Perez, M., Valpuesta, J.M. & Avila, J. (1997) Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am. J. Pathol. 151, 1115-1122.
50. 50. Castillo, G.M., Lukito, W., Wight, T.N. & Snow, A.D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation. J. Neurochem. 72, 1681-1687.
51. 51. Jiang, X., Myatt, E., Lykos, P. & Stevens, F.J. (1997) Interaction between glycosaminoglycans and immunoglobulin light chains. Biochemistry 36, 13187-13194.
52. 52. McCubbin, W.D., Kay, C.M., Narindrasorasak, S. & Kisilevsky, R. (1988) Circular-dichroism studies on two murine serum amyloid A proteins. Biochem. J. 256, 775-783.
53. 53. Fraser, P.E., McLachlan, D.R., Surewcz, W.K., Mizzen, C.A., Snow, A.D., Nguyen, J.T. & Kirschner, D.A. (1994) Conformation and fibrillogenesis of Alzheimer A β peptides with selected substitution of charged residues. J. Mol. Biol. 244, 64-73.
54. 54. Levengle, B., Scanameo, A., Ding, W. & Fillit, H. (1994) Binding of heparan sulfate glycosaminoglycan to β-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. Neuroreport 5, 1389-1392.
55. 55. Kisilevsky, R., Lemieux, L.J., Fraser, P.E., Kong, X., Hultin, P.G. & Szarek, W. (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates implications for Alzhcimer's disease. Nature Med. 1, 143-148.